
Opinion|Videos|February 6, 2025
Adverse Effects Associated With Hypophosphatemia
Panelists discuss how hypophosphatemia can cause both acute effects like muscle weakness and confusion and chronic complications such as osteomalacia and metabolic disturbances, potentially impacting patients’ mobility, energy levels, and overall quality of life if not properly monitored and managed.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the short- and long-term effects of hypophosphatemia? How do these impact patients’ daily lives?
Advertisement
Related to this article

Non-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.

The once weekly self-injected treatment is the first dual-binding nanobody C5 inhibitor approved for adults with AChR antibody-positive gMG.

Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.

Non-CF bronchiectasis prevalence rose across commercial, Medicare, and Medicaid plans from 2016 to 2024, while incidence stayed relatively stable.

Shorter telomere length was linked to a usual interstitial pneumonia pattern (UIP) on CT in patients with ILD, per research presented at CHEST 2026.

Low awareness that fatty liver can silently progress and that MASH fibrosis is treatable drives missed follow-up testing, says Rohit Loomba, MD.
Advertisement
Advertisement
Trending on AJMC
1
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
2
FDA Approves Weekly Gefurulimab for Generalized Myasthenia Gravis
3
Nondrug Therapies Ease Cough in Lung Cancer, Pulmonary Rehab Leads Pack
4
FDA Approves Dexmedetomidine Sublingual Film as At-Home Agitation Therapy
5

